Beauty and Personal Care M&A — Q3 2026

Tariff whiplash combined with a shaky economy and volatile geopolitical climate kept a lot of buyers on the sidelines in 2025. Coming into 2026, the mood has shifted. Borrowing money is cheaper, private equity firms are under pressure to spend the cash they’ve raised and several of the big companies spent last year cutting brands that no longer fit their strategy.

The first half of 2026 backed that up with billion-dollar deals: Henkel acquired Olaplex for $1.4 billion, L’Oréal completed its ~$4.6 billion acquisition purchase of Kering Beauté, and Unilever spent $1.2 billion to expand into wellness with Grüns. With buyers still flush with cash and legacy brands under pressure to stay relevant, we’d expect that pace to hold through the rest of the year and into 2027.

Key Takeaways

• Beauty and Personal Care M&A is heating up and pricing at a premium
• Buyers are looking beyond novelty and are paying for proof. Clinical efficacy, defensible IP and recurring, loyal customers are commanding premium valuations
• Cosmoprof 2026 confirmed the shift from aesthetics to results, and ingredient transparency now trumping “clean beauty” claims
• AI-led diagnostics, personalization and social ecommerce are reshaping discovery and fueling investor interest in digital/DTC platforms
• Timing is a strategic decision, not just a market condition. Every industry gets its moment in the M&A cycle, and Beauty and Personal Care is in right now

For more information, please contact Sophea Chau, Senior Managing Director, at 617.603.8963.